TrialThe Journal of infectious diseases2011

High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.

Anuradha Ganesan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.